Chahal HS, Stals K, Unterlander M, et al. AIP mutation in pituitary adenomas in the 18th century and today. N Engl J Med. 2011 Jan 6. 364(1):43-50. [Medline].
Vargas G, Gonzalez B, Ramirez C, et al. Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas. Int J Endocrinol. 2015. 2015:756069. [Medline].
Alimohamadi M, Sanjari R, Mortazavi A, Shirani M, Moradi Tabriz H, Hadizadeh Kharazi H, et al. Predictive value of diffusion-weighted MRI for tumor consistency and resection rate of nonfunctional pituitary macroadenomas. Acta Neurochir (Wien). 2014 Dec. 156(12):2245-52. [Medline].
Gupta K, Sahni S, Saggar K, Vashisht G. Evaluation of Clinical and Magnetic Resonance Imaging Profile of Pituitary Macroadenoma: A Prospective Study. J Nat Sci Biol Med. 2018 Jan-Jun. 9 (1):34-8. [Medline].
Greenman Y, Stern N. How should a nonfunctioning pituitary macroadenoma be monitored after debulking surgery?. Clin Endocrinol (Oxf). 2009 Jun. 70(6):829-32. [Medline].
Parhar PK, Duckworth T, Shah P, et al. Decreasing Temporal Lobe Dose with Five-Field Intensity-modulated Radiotherapy for Treatment of Pituitary Macroadenomas. Int J Radiat Oncol Biol Phys. 2009 Dec 14. [Medline].
Loeffler JS, Shih HA. Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab. 2011 Jul. 96(7):1992-2003. [Medline].
Marek J, Jezkova J, Hana V, et al. Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife?. Eur J Endocrinol. 2011 Feb. 164(2):169-78. [Medline].
Wu JS, Shou XF, Yao CJ, et al. Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low-field intraoperative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging. Neurosurgery. 2009 Jul. 65(1):63-70; discussion 70-1. [Medline].
Fomekong E, Maiter D, Grandin C, et al. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas. Clin Neurol Neurosurg. 2009 Jun. 111(5):442-9. [Medline].
Theodosopoulos PV, Leach J, Kerr RG, et al. Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging?. J Neurosurg. 2009 Oct 16. [Medline].
Pinar E, Yuceer N, Imre A, Guvenc G, Gundogan O. Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas. J Craniofac Surg. 2014 Dec 2. [Medline].
Paek SH, Downes MB, Bednarz G, Keane WM, Werner-Wasik M, Curran WJ Jr, et al. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int J Radiat Oncol Biol Phys. 2005 Mar 1. 61(3):795-808. [Medline].
Han S, Ding X, Tie X, Liu Y, Xia J, Yan A, et al. Endoscopic endonasal trans-sphenoidal approach for pituitary adenomas: Is one nostril enough?. Acta Neurochir (Wien). 2013 Jun 5. [Medline].
Mao ZG, Zhu YH, Tang HL, et al. Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomized trial. Eur J Endocrinol. 2010 Jan 8. [Medline].
Przybylowski CJ, Dallapiazza RF, Williams BJ, et al. Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: matched cohort study. J Neurosurg. 2016 May 20. 1-8. [Medline].
Magro E, Graillon T, Lassave J, et al. Complications Related to the Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Macroadenomas in 300 Consecutive Patients. World Neurosurg. 2016 May. 89:442-53. [Medline].
Sankhla SK, Jayashankar N, Khan GM. Surgical management of selected pituitary macroadenomas using extended endoscopic endonasal transsphenoidal approach: early experience. Neurol India. 2013 Mar-Apr. 61(2):122-30. [Medline].
Berkmann S, Fandino J, Zosso S, et al. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions. J Neurosurg. 2011 Sep. 115(3):518-27. [Medline].
Hisanaga S, Kakeda S, Yamamoto J, et al. Pituitary Macroadenoma and Visual Impairment: Postoperative Outcome Prediction with Contrast-Enhanced FIESTA. AJNR Am J Neuroradiol. 2017 Nov. 38 (11):2067-72. [Medline].
Thawani JP, Ramayya AG, Pisapia JM, Abdullah KG, Lee JY, Grady MS. Operative Strategies to Minimize Complications Following Resection of Pituitary Macroadenomas. J Neurol Surg B Skull Base. 2017 Apr. 78 (2):184-90. [Medline].
Johnston PC, Kennedy L, Hamrahian AH, et al. Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience. Pituitary. 2017 Mar 6. [Medline].
Elhateer H, Muanza T, Roberge D, et al. Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas. Curr Oncol. 2008 Dec. 15(6):286-92. [Medline]. [Full Text].
Schalin-Jäntti C, Valanne L, Tenhunen M, et al. Outcome of Fractionated Stereotactic Radiotherapy in Patients with Pituitary Adenomas Resistant to Conventional Treatments: a 5.25- yr Follow-up Study. Clin Endocrinol (Oxf). 2009 Dec 18. [Medline].
Watts AK, Easwaran A, McNeill P, Wang YY, Inder WJ, Caputo C. Younger age is a risk factor for regrowth and recurrence of nonfunctioning pituitary macroadenomas: Results from a single Australian centre. Clin Endocrinol (Oxf). 2017 Sep. 87 (3):264-71. [Medline].
Raverot G, Burman P, McCormack AI, et al. European Society of Endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 2017 Oct 18. [Medline]. [Full Text].
Mello PA, Naves LA, Pereira Neto A, Oliveira EH, Ferreira IC, Araújo Júnior AS, et al. Clinical and laboratorial characterization and post-surgical follow-up of 87 patients with non-functioning pituitary macroadenomas. Arq Neuropsiquiatr. 2013 May. 71(5):307-12. [Medline].
Laws ER Jr, Iuliano SL, Cote DJ, Woodmansee W, Hsu L, Cho CH. A Benchmark for Preservation of Normal Pituitary Function After Endoscopic Transsphenoidal Surgery for Pituitary Macroadenomas. World Neurosurg. 2016 Jul. 91:371-5. [Medline].
Hwang YC, Chung JH, Min YK, et al. Comparisons between macroadenomas and microadenomas in Cushing's disease: characteristics of hormone secretion and clinical outcomes. J Korean Med Sci. 2009 Feb. 24(1):46-51. [Medline]. [Full Text].
Fernandez-Balsells MM, Murad MH, Barwise A, et al. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2011 Apr. 96(4):905-12. [Medline].
